‘Pharma Bro’ Martin Shkreli Hit With $64.6 Million Fine And Lifetime Ban From Pharma Industry

Описание: A federal judge ruled Friday morning that Martin Shkreli, a former hedge fund manager convicted of securities fraud in 2017, must pay $64.6 million in fines to states that filed an antitrust lawsuit over his dramatic increase to the price of Daraprim, a life-saving drug, in 2015.

READ MORE: https://www.forbes.com/sites/carliepo...

Stay Connected
Forbes on Facebook: http://fb.com/forbes
Forbes Video on Twitter:   / forbes  
Forbes Video on Instagram:   / forbes  
More From Forbes: http://forbes.com